American International Group
AIG
$79.63
+2.42%
American International Group (AIG) is one of the world's largest diversified insurance and financial services organizations, underwriting property, casualty, and specialty lines through its core General Insurance segment while retaining a minority stake in the spun-off life and retirement business, Corebridge Financial. AIG occupies a distinctive position as a global P&C underwriting powerhouse with a truly multinational footprint, but it is no longer the sprawling financial conglomerate of its pre-crisis past — management has deliberately repositioned the company as a leaner, underwriting-focused specialty insurer with a smaller, more capital-efficient operating base. The current investor narrative centers on the durability of underwriting margins and investment income following the Q3 2026 earnings beat, where AIG exceeded consensus on the back of strong net investment income, even as the stock trades near the middle of its 52-week range and has lagged the broader market on a year-to-date basis. Debate now hinges on whether the post-Corebridge simplification story has further re-rating upside, or whether the shares are fairly valued given the market-like growth profile and a consensus that skews cautious despite a nominal "buy" label.…
AIG
American International Group
$79.63
Related headlines
Investment Opinion: Should I buy AIG Today?
Rating: Hold, with a constructive lean toward accumulating on weakness. The core thesis is that AIG is a cheap, capital-returning P&C underwriter whose 8.87x forward PE and 1.18x P/B already discount a lot of skepticism, but whose 7.53% ROE and 2.32 recommendation mean (functionally a Hold) mean there is no near-term catalyst to force a re-rating. The analyst consensus average target of $88.40 implies +13.7% upside from $77.75, and with 0 of 20 analysts at Sell and a low target of $80.00 (2.9% above spot), the risk/reward skews modestly positive rather than compelling.
Supporting evidence is genuinely mixed but tilts to the bulls on valuation and cash generation. AIG trades at 8.87x forward earnings versus 15.6x trailing — a 43% compression that implies consensus EPS of $9.51 versus the trailing figure — and at 1.18x P/B, 1.81x P/S, and 7.28x EV/EBITDA, all at or below typical diversified-insurer levels. Revenue re-accelerated 16.26% YoY to $7.443 billion in Q3 2026, net income rose to $849 million from $519 million a year earlier (EPS $1.61 vs $0.94), and TTM free cash flow of $5.198 billion funded roughly 200 million shares retired in two years (621M in Q4 2024 to 523M in Q3 2026). The 2.02% dividend yield on a 31.5% payout ratio and 0.223 debt-to-equity leave room for both.
The biggest risks that could invalidate the thesis are margin durability, the value-trap discount, and relative underperformance. Gross margin fell from 47.7% in Q1 2026 to 33.4% in Q3 and operating margin slipped to 16.4% from 19.3%, so the forward multiple depends on investment income and underwriting margins delivering the $9.51 EPS step-up; a soft commercial P&C pricing cycle would break that. AIG has lagged SPY by 15.57% YTD and 7.66% over twelve months, and its 0.475 beta means it will keep lagging in risk-on rallies. This Hold would upgrade to Buy if forward PE stays below 9x while gross margin stabilizes above ~35% and EPS tracks toward $9.51, or downgrade to Sell if underwriting margins compress further and the stock breaks its $71.25 52-week low. Verdict: fairly valued to modestly undervalued relative to its own history (P/B near the low end of its recent ~1.0x–1.25x band) and to peers, but not mispriced enough to justify a high-conviction Buy.
Sign up to view all
AIG 12-Month Price Forecast
AIG screens as a fairly valued, low-beta value insurer rather than a growth story: the 8.87x forward PE and 1.18x P/B are cheap in absolute terms, but the 7.53% ROE and 11.6% net margin justify at least part of that discount versus higher-quality specialty peers. The bull case rests on durable capital return — $5.198 billion TTM free cash flow and roughly 200 million shares retired in two years — plus 16.26% revenue growth, while the bear case points to margin compression, a 2.32 recommendation mean that is really a Hold, and persistent market underperformance. With 0 Sell ratings and a $80.00 low target above spot, downside appears limited to roughly -8% to -17% (52-week low $71.25 to the -16.98% max drawdown), while the base case points to the $88.40 average target. I would upgrade to bullish if Q4 shows gross margin stabilizing above ~35% and EPS tracking toward $9.51, and downgrade to bearish if underwriting margins compress further or the stock breaks $71.25.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on American International Group's 12-month outlook, with a consensus price target around $88.40 and implied upside of +11.0% versus the current price.
Average Target
$88.40
22 analysts
Implied Upside
+11.0%
vs. current price
Analyst Count
22
covering this stock
Price Range
$80 - $100
Analyst target range
Coverage is broad, with 20 analysts publishing ratings, but the sentiment is decidedly mixed. The distribution is 8 Buy, 14 Hold, and 0 Sell, yielding a consensus recommendation of "buy" on paper but a recommendation mean of 2.32 — which on a 1-to-5 scale (1 = strong buy, 5 = strong sell) actually lands closer to Hold than Buy. The average target price of $88.40 implies roughly +13.7% upside from the current $77.75, a respectable but not aggressive return expectation that is consistent with a fairly-valued, low-beta insurer rather than a high-conviction growth call.
The target range of $80.00 to $101.00 is moderately wide, signaling meaningful dispersion in assumptions. Notably, even the low target of $80.00 sits about 2.9% above the current price, meaning no covering analyst sees downside — a bullish structural signal, though the tight floor may simply reflect stale targets rather than fresh conviction. The high target of $101.00 (about +30% upside) would require multiple expansion toward the upper end of AIG's historical P/B band plus sustained investment-income strength, while the low end implies the stock merely mean-reverts to fair value. Institutional ratings show a stable, unexcited pattern: recent actions from Wells Fargo (Equal Weight), Morgan Stanley (Equal Weight), Mizuho (Neutral), and KBW/UBS/Argus/Cantor (Buy/Outperform/Overweight) are almost all reiterations rather than upgrades or downgrades, suggesting analysts are waiting for a clearer catalyst before changing their stance.
Drowning in data?
Find the real signal!
Bulls vs Bears: AIG Investment Factors
The bear case currently has slightly stronger near-term evidence: AIG has lagged the market by 15.57% year-to-date, the analyst consensus mean of 2.32 is functionally a Hold, and the most recent session showed a 3.93% reversal on heavy volume. The bull case rests on valuation and capital return — an 8.87x forward PE, a 1.18x P/B near the low end of its recent range, 16.26% revenue growth, and roughly 200 million shares retired in two years — which is a durable but slow-compounding story rather than a catalyst-driven one. The single most important tension is whether the 43% gap between trailing (15.6x) and forward (8.87x) PE is validated by the expected EPS step-up to $9.51; if investment income and underwriting margins deliver that earnings growth, the stock re-rates, but if they disappoint, the "cheap" multiple is simply the market correctly pricing a decelerating insurer. Absent a clear catalyst, the stock is likely to remain range-bound between $71.25 and $87.29.
Bullish
- Forward PE of 8.87x prices in skepticism: AIG trades at just 8.87x forward earnings versus 15.6x trailing, a 43% compression that implies consensus EPS of $9.51 versus the current trailing figure. That multiple sits well below the broader market's high-teens level and at or below typical diversified-insurer valuations, leaving room for re-rating if underwriting and investment income hold.
- Revenue re-accelerating at 16.3% YoY: Q3 2026 revenue of $7.443 billion rose 16.26% from $6.402 billion a year earlier, extending a steady sequence of $6.657B (Q1), $7.085B (Q2), and $7.443B (Q3). The General Insurance segment contributed $6.72 billion of that total, confirming the post-Corebridge P&C underwriting engine is driving growth.
- Aggressive buyback shrinking share count: Shares outstanding fell from roughly 621 million in Q4 2024 to 523 million in Q3 2026 — about 200 million shares retired in two years — funded by $5.198 billion of TTM free cash flow and $2.691 billion of Q3 operating cash flow. This per-share accretion is a structural tailwind independent of multiple expansion.
- No analyst sees downside from here: The lowest of 20 analyst targets is $80.00, about 2.9% above the current $77.75, while the average target of $88.40 implies +13.7% upside and the high of $101.00 implies roughly +30%. With 8 Buy, 14 Hold, and 0 Sell ratings, the distribution is cautious but structurally floor-supported.
Bearish
- Consensus is really a Hold in disguise: Despite a nominal "buy" label, the recommendation mean of 2.32 on a 1-to-5 scale lands closer to Hold than Buy, with 14 of 20 analysts at Hold. Recent actions from Wells Fargo, Morgan Stanley, and Mizuho were Equal Weight or Neutral reiterations, suggesting analysts see no near-term catalyst to change their stance.
- Persistent underperformance versus the market: AIG is down 7.74% year-to-date versus the S&P's +7.83%, a -15.57% relative strength gap, and has gained only 1.93% over twelve months against SPY's 9.59% (-7.66% relative). The low beta that cushions drawdowns also guarantees it lags in risk-on rallies, as this record demonstrates.
- Mediocre returns on capital: ROE of 7.53% and ROA of 1.95% are modest even for a capital-intensive insurer, and the 11.6% net margin is respectable but not best-in-class. This quality gap arguably justifies the discount to higher-quality specialty insurers rather than representing a pure mispricing.
- Gross margin compressing through the year: Gross margin fell from 47.7% in Q1 2026 to 36.7% in Q2 and 33.4% in Q3, and operating margin slipped to 16.4% in Q3 from 19.3% in Q2. Management attributes this to mix shift, but the trend bears watching if it reflects pricing pressure in P&C lines.
AIG Technical Analysis
AIG is in a broad, range-bound consolidation rather than a clean directional trend. Over the trailing twelve months the stock has gained just 1.93%, materially underperforming SPY's 9.59% advance (relative strength of -7.66%), and year-to-date it is down 7.74% versus the S&P's +7.83% (relative strength of -15.57%). At the current price of $77.75, the stock sits roughly 39% of the way up its 52-week range of $71.25 to $87.29 — closer to the lower half than the highs, which frames this as a value/mean-reversion setup rather than a momentum breakout, though the stock is well off its 52-week low and not a falling knife. The maximum drawdown of -16.98% over the period underscores that this is a low-beta, slow-grinding name rather than a high-volatility trader.
Short-term momentum has actually turned constructive and is diverging positively from the weak longer-term trend. The stock is up 2.76% over the past month against a -4.99% decline in SPY, producing a striking +7.75% relative strength reading — one of the strongest one-month outperformance gaps in the dataset. That said, the three-month change of -1.31% (versus SPY -4.91%, +3.60% relative) and six-month change of +1.82% show the recovery is recent and uneven rather than a sustained acceleration. The most recent session is a sharp negative tell: the stock fell 3.93% from a previous close of $80.93 to $77.75 on elevated volume of roughly 4.63 million shares, suggesting the post-earnings pop has partially reversed and near-term momentum may be decelerating even as the monthly trend stays positive.
Key technical levels are well defined. Support sits at the 52-week low of $71.25, roughly 8.4% below the current price, while resistance is anchored at the 52-week high of $87.29, about 12.3% above — a breakdown below $71.25 would signal the consolidation is resolving lower and likely reflect deteriorating underwriting or investment-income expectations, whereas a breakout above $87.29 would confirm a new leg higher and likely require a fundamental catalyst. The beta of 0.475 is the critical risk-management input: AIG is roughly half as volatile as the market, meaning position sizing can be larger for the same risk budget, but it also means the stock will lag in strong risk-on rallies — consistent with its -7.66% one-year relative underperformance during a period when SPY rose nearly 10%.
Beta
0.47
0.47x market volatility
Max Drawdown
-17.0%
Largest decline past year
52-Week Range
$71-$87
Price range past year
Annual Return
+3.5%
Cumulative gain past year
| Period | AIG Return | S&P 500 |
|---|---|---|
| 1m | +3.4% | -3.3% |
| 3m | +3.0% | -2.3% |
| 6m | +5.1% | +1.4% |
| 1y | +3.5% | +12.2% |
| ytd | -5.5% | +10.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AIG Fundamental Analysis
AIG's revenue trajectory is clearly re-accelerating. Most recent quarterly revenue for Q3 2026 came in at $7.443 billion, up 16.26% year-over-year versus $6.402 billion in Q3 2025, and the multi-quarter sequence shows steady expansion: $6.657 billion in Q1 2026, $7.085 billion in Q2 2026, and $7.443 billion in Q3 2026. The General Insurance segment is the engine, contributing $6.72 billion of segment revenue, while Corporate Nonsegment and Reconciling Items add a modest $123 million and total reconciling items subtract $92 million — confirming this is now a concentrated P&C underwriting story. The acceleration from the prior-year comps supports the thesis that premium growth and investment income are both contributing, which is a meaningful positive for the investment case given the market's skepticism about growth durability.
Profitability is solid and margins are holding at healthy insurance-industry levels. Q3 2026 net income was $849 million on a net margin of 11.4%, with gross margin of 33.4% and operating margin of 16.4%; the trailing-twelve-month net margin of 11.56% and operating margin of 14.49% are consistent with a well-run diversified insurer. The quarterly progression shows some margin volatility — gross margin was 47.7% in Q1 2026, 36.7% in Q2, and 33.4% in Q3 — but net income has been remarkably stable at $763 million, $948 million, and $849 million across those quarters, and the Q3 2025 net margin of just 8.1% shows meaningful year-over-year improvement. With EPS of $1.61 in Q3 2026 versus $0.94 a year earlier, earnings power is expanding even as the headline gross margin compresses, reflecting a mix shift rather than deterioration.
Balance sheet and cash generation are the quiet strength of the story. Debt-to-equity is a conservative 0.223, total debt-to-capitalization sits near 21%, and interest coverage is a comfortable 12.1x — well within investment-grade comfort for an insurer. Free cash flow TTM is a robust $5.198 billion, and Q3 2026 alone generated $2.691 billion of operating cash flow, funding $529 million of buybacks and $260 million of dividends in the quarter. ROE of 7.53% and ROA of 1.95% are modest in absolute terms but normal for a capital-intensive insurer, and the 2.02% dividend yield with a 31.5% payout ratio leaves ample room for continued buybacks — the company retired roughly 200 million shares over two years (from ~621 million in Q4 2024 to ~523 million in Q3 2026), a powerful per-share value driver.
Quarterly Revenue
$7.4B
2026-09
Revenue YoY Growth
+16.3%
YoY Comparison
Gross Margin
33.4%
Latest Quarter
Free Cash Flow
$5.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AIG Overvalued?
Because AIG is solidly profitable (Q3 2026 net income of $849 million; TTM EPS positive), the PE ratio is the appropriate primary metric. The stock trades at 15.6x trailing earnings but only 8.87x forward earnings — a dramatic 43% compression that implies the market expects a substantial earnings step-up, consistent with consensus EPS estimates of $9.51 versus the current trailing figure. The forward multiple of 8.87x is the key valuation anchor: it prices AIG as a cheap, mature insurer rather than a growth story, and the gap between trailing and forward PE is the market's implicit bet that investment income and underwriting margins will normalize higher.
On peer comparison, AIG screens cheap across most measures. Price-to-book of 1.18x, price-to-sales of 1.81x, and EV/EBITDA of 7.28x are all at or below typical diversified-insurer levels, and the 8.87x forward PE sits well under the broader market's high-teens multiple. The PEG ratio of -0.04 is not meaningful given the sign of the earnings growth input, so it should be disregarded. The premium/discount question is really about quality: AIG's 11.6% net margin and 7.5% ROE are respectable but not best-in-class, which argues the discount to higher-quality specialty insurers is at least partly justified rather than a pure mispricing.
Historically, AIG's valuation has been volatile but is now in the lower-middle of its own band. The PE ratio has ranged from single digits (10.4x in Q2 2026, 11.6x in Q3 2026) up to 20.9x in Q3 2025 and 15.7x in Q4 2025, while price-to-book has drifted from 1.25x in Q1 2025 down to roughly 1.0x in Q3 2026 — near the low end of its recent range. That combination of a depressed P/B and a mid-range PE suggests the market is pricing in modest expectations: not a distressed valuation, but one that leaves room for re-rating if underwriting margins hold and buybacks continue to shrink the share count.
PE
15.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 3x~25x
vs. Industry Avg
14.2x
Industry PE ~14.2x*
EV/EBITDA
7.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on earnings quality and margin durability. Gross margin compressed from 47.7% in Q1 2026 to 33.4% in Q3, and operating margin fell from 19.3% to 16.4% over the same span, so the forward PE of 8.87x depends on consensus EPS of $9.51 materializing against a trailing figure far lower — a bet on investment income and underwriting margins normalizing higher. The current ratio of 0.853 is below 1.0, and ROE of 7.53% is modest, meaning there is limited cushion if catastrophe losses or reserve strengthening hit a concentrated P&C book where General Insurance alone contributed $6.72 billion of Q3 revenue. The buyback that retired roughly 200 million shares in two years is funded by $5.198 billion of TTM free cash flow; a downturn in underwriting results would force a choice between sustaining repurchases and preserving capital. Market and competitive risks are dominated by the valuation-compression question. At 1.18x P/B and 8.87x forward earnings, AIG already trades at a discount to higher-quality specialty insurers, so the risk is less multiple compression than a persistent "value trap" discount if ROE stays near 7.5% while peers earn more. The 0.475 beta means AIG will lag in strong risk-on rotations — it underperformed SPY by 15.57% year-to-date during a +7.83% market advance — and the 14 Hold ratings with a 2.32 recommendation mean suggest analysts see no catalyst to close that gap. Competitive pressure in P&C pricing and any softening of the commercial insurance cycle would directly hit the underwriting margins the forward valuation assumes. The worst-case scenario is a chain in which a soft commercial P&C pricing cycle coincides with weaker investment income and elevated catastrophe losses, compressing underwriting margins just as the market expected the $9.51 EPS step-up. In that case the forward multiple would prove illusory and the stock would retest its 52-week low of $71.25, roughly 8.4% below the current $77.75; a deeper derating toward the historical low-end P/B of ~1.0x from the current 1.18x would imply a similar single-digit to low-double-digit percentage decline. The observed maximum drawdown over the past year was -16.98%, so a realistic adverse outcome is a loss of roughly -8% to -17% from current levels, with the analyst low target of $80.00 offering no real downside protection since it sits only 2.9% above the current price.
FAQ
The most severe risk is margin durability: gross margin fell from 47.7% in Q1 2026 to 33.4% in Q3 and operating margin slipped from 19.3% to 16.4%, so the 8.87x forward PE depends on a $9.51 EPS step-up that a soft commercial P&C pricing cycle could derail. Second is earnings concentration and balance-sheet flexibility — General Insurance alone contributed $6.72 billion of Q3 revenue, the current ratio is 0.853 (below 1.0), and a catastrophe-loss or reserve-strengthening event would force a choice between sustaining the buyback and preserving capital. Third is relative-performance and valuation risk: the 0.475 beta means AIG lags in risk-on rallies, as shown by -15.57% relative strength YTD versus a +7.83% S&P, and a persistent value-trap discount could keep P/B near 1.0x even if earnings hold. Fourth is macro and rate sensitivity — investment income is a key earnings driver, so falling rates or portfolio yield compression would hit the very earnings the forward multiple assumes. Ranked by severity: margin/underwriting risk first, catastrophe and reserve risk second, relative-performance and valuation risk third, and rate-driven investment-income risk fourth.
The 12-month forecast is anchored by three scenarios. The base case (60% probability, $80.00-$88.40) assumes forward PE holds near 8.87x as EPS approaches the $9.51 consensus, gross margin stabilizes in the mid-30s, and free cash flow near $5.2 billion sustains buybacks and the dividend, converging on the $88.40 average target (+13.7%). The bull case (20%, $95.00-$101.00) requires underwriting margins to stabilize, investment income to stay strong, and multiple expansion toward the upper end of AIG's historical P/B band, reaching the $101.00 analyst high (+30%). The bear case (20%, $71.25-$80.00) envisions a soft P&C pricing cycle coinciding with weaker investment income and elevated catastrophe losses, retesting the $71.25 52-week low (-8.4%) and potentially a low-double-digit decline consistent with the -16.98% max drawdown. The base case is most likely, and its key assumption is that the 43% trailing-to-forward PE compression is validated by delivered earnings rather than being an illusion.
AIG screens as fairly valued to modestly undervalued. The stock trades at 15.6x trailing earnings but only 8.87x forward earnings — a 43% compression implying consensus EPS of $9.51 versus the current trailing figure — alongside 1.18x price-to-book, 1.81x price-to-sales, and 7.28x EV/EBITDA, all at or below typical diversified-insurer levels. Against its own history, P/B has drifted from 1.25x in Q1 2025 to roughly 1.0x in Q3 2026, placing it near the low end of its recent band, while the PE has ranged from 10.4x to 20.9x over the past year. The market is therefore paying a discount rather than a premium, but that discount is partly earned: an 11.6% net margin and 7.53% ROE are respectable rather than best-in-class, which justifies some gap to higher-quality specialty peers. The valuation implies the market expects only modest earnings normalization and continued capital return, not a growth re-rating — leaving room for upside if underwriting margins hold, but little cushion if they do not.
From a risk/reward standpoint AIG is a modestly positive but not compelling buy: the $88.40 average analyst target implies +13.7% upside from $77.75, and with 0 of 20 analysts at Sell and a low target of $80.00 (2.9% above spot), the downside appears structurally limited. The valuation is genuinely cheap at 8.87x forward earnings and 1.18x book, and $5.198 billion of TTM free cash flow funds both the 2.02% dividend and a buyback that retired roughly 200 million shares in two years. However, the 2.32 recommendation mean is functionally a Hold, ROE of 7.53% is mediocre, and the stock has lagged SPY by 15.57% YTD, so there is no obvious catalyst to force a re-rating. The biggest downside risk is a retest of the $71.25 52-week low, roughly -8.4%, or a deeper derating consistent with the -16.98% max drawdown. It is a reasonable buy for patient value and income investors comfortable with low-beta, market-like returns, but not for anyone seeking near-term momentum or high growth.
AIG is better suited to long-term holding than short-term trading. Its 0.475 beta means roughly half the market's volatility, which supports larger position sizing for a given risk budget but also guarantees it lags in strong risk-on rallies — as the -7.66% one-year relative underperformance during a period when SPY rose 9.59% demonstrates. The return engine is slow-compounding capital return: a 2.02% dividend yield on a 31.5% payout ratio plus a buyback that retired about 200 million shares in two years, which rewards patience rather than timing. Earnings visibility is reasonable but not exceptional given quarterly margin volatility (gross margin 47.7% to 33.4% across 2026) and sensitivity to catastrophe losses and P&C pricing. Short-term traders face a range-bound setup between $71.25 and $87.29 with a recent 3.93% single-session reversal on 4.63 million shares, offering thin edge. A concrete minimum holding period of 12-24 months is appropriate to let the buyback compound and to allow the base-case convergence toward the $88.40 average target to play out.